Publication Cover
Chronobiology International
The Journal of Biological and Medical Rhythm Research
Volume 32, 2015 - Issue 9
188
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Circadian variation in murine hepatotoxicity to the antituberculosis agent «Isoniazide»

, , , , , , , , & show all
Pages 1201-1210 | Received 09 Jun 2015, Accepted 29 Jul 2015, Published online: 19 Oct 2015
 

Abstract

The circadian time is an important process affecting both pharmacokinetics and pharmacodynamics of drugs. Consequently, the desired and/or undesired effects vary according to the time of drug administration in the 24 h scale. This study investigates whether the toxicity in liver as well as oxidative stress varies according to the circadian dosing-time of isoniazid (INH) in mice. A potentially toxic INH dose (120 mg/kg) was injected by i.p. route to different groups of animals at three different circadian times: 1, 9, and 17 Zeitgeber time (ZT). INH administration at 1 ZT resulted in a maximum hepatotoxicity assessed by the significant increase in both serum transaminase (ALAT: alanine aminotransferase) and (ASAT: aspartate aminotransferase) and antioxidant enzyme activities (catalase: CAT and superoxide dismutase: SOD). The highest malondialdehyde (MDA) level indicating an induction of lipid peroxidation resulting in oxidative damage was also observed at 1 ZT. Liver histopathology from INH groups at 9 ZT and at 1 ZT showed moderate to severe cytoplasma vacuolation, hepatocyte hypertrophy, ballooning, and necrosis. The circadian variation in INH toxicity may help realize a chronotherapy protocol in humans based on the selection of the best time associated to optimal tolerance or least side effects.

Acknowledgements

The authors would like to thank Mr. Adel Rdissi for proof reading this article.

Declaration of interest

The authors report no conflicts of interest. This work was supported by the Tunisian Ministry of ‘‘Enseignement Superieur, Recherche Scientifique et Technologie’’.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.